A CASE REPORT OF SUCCESSFUL STEROID TREATMENT IN INFANT WITH EXTRAHEPATIC CHOLESTASIS
Downloads
Background: Cholestatic jaundice in infants is a significant healthcare challenge, particularly in regions where access to surgical intervention and liver transplantation is limited. An immunologic mechanism underlies the pathogenesis of biliary atresia leading to fibro-obliteration of the bile ducts. However, the successful management of biliary atresia is often difficult because treatment typically occurs at an advanced stage. Therefore, alternative therapies that can suppress bile duct inflammation are urgently needed. Administering anti-inflammatory drugs such as methylprednisolone to infants in the early stages of cholestasis may provide opportunities to improve outcomes in the limited capacity to perform Kasai surgery and liver transplantation. Purpose: This case report describes the clinical improvement of extrahepatic cholestasis following steroid administration. Case analysis: We report a case of a 24-day-old male infant presenting with clinical symptoms of jaundice and pale stool. Liver biopsy revealed features consistent with extrahepatic obstructive cholestasis characteristic of biliary atresia. The patient was treated with methylprednisolone (a corticosteroid) and ursodeoxycholic acid without surgical intervention. Result: The combination of methylprednisolone and ursodeoxycholic acid normalized liver function tests and led to significant clinical improvement. Both jaundice and pale stools completely resolved within two months of treatment. Conclusion: Steroid therapy may provide clinical benefits for infants with extrahepatic cholestasis, particularly in settings with limited healthcare resources. Steroid administration may play a role in the suppression of the inflammatory process that causes fibrosis and bile duct obliteration in the early stages of the disease.
Aziz, S., Wild, Y., Rosenthal, P., Goldstein, R.B., 2011. Pseudo Gallbladder Sign in Biliary Atresia—An Imaging Pitfall. Pediatric Radiology Vol. 41(5), Pp. 620-626.
Butler, A.E., Schreiber, R.A., Yanchar, N., Emil, S., Laberge, J.-M., Canadian Biliary Atresia Registry, 2016. The Canadian Biliary Atresia Registry: Improving The Care of Canadian Infants with Biliary Atresia. Paediatrics & Child Health Vol. 21(3), Pp. 131-134.
Coutinho, A.E., Chapman, K.E., 2011. The Anti-Inflammatory and Immunosuppressive Effects of Glucocorticoids, Recent Developments and Mechanistic Insights. Molecular and Cellular Endocrinology Vol. 335(1), Pp. 2-13.
Davenport, M., Tizzard, S.A., Underhill, J., Mieli-Vergani, G., Portmann, B., Hadzić, N., 2006. The Biliary Atresia Splenic Malformation Syndrome: A 28-Year Single-Center Retrospective Study. The Journal of Pediatrics Vol. 149(3), Pp. 393-400.
Dong, R., Zhao, R., Zheng, S., 2011. Changes in Epigenetic Regulation of CD4+ T Lymphocytesin Biliary Atresia. Pediatric Research Vol. 70(6), Pp. 555-559.
Fawaz, R., Baumann, U., Ekong, U., Fischler, B., Hadzic, N., Mack, C.L., McLin, V.A., Molleston, J.P., Neimark, E., Ng, V.L., Karpen, S.J., 2017. Guideline for the Evaluation of Cholestatic Jaundice in Infants: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and The European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. Journal of Pediatric Gastroenterology and Nutrition Vol. 64(1), Pp. 154-168.
Feldman, A.G., Sokol, R.J., 2021. Neonatal Cholestasis: Updates on Diagnostics, Therapeutics, and Prevention. NeoReviews Vol. 22(12), Pp. e819–e836.
Götze, T., Blessing, H., Grillhösl, C., Gerner, P., Hoerning, A., 2015. Neonatal Cholestasis - Differential Diagnoses, Current Diagnostic Procedures, and Treatment. Frontiers in Pediatrics Vol. 3, Pp. 43.
Harpavat, S., Finegold, M.J., Karpen, S.J., 2011. Patients with Biliary Atresia Have Elevated Direct/Conjugated Bilirubin Levels Shortly After Birth. Pediatrics Vol. 128 (6), Pp. e1428-e1433.
Hodgson, J.M., van Someren, V.H., Smith, C., Goyale, A., 2018. Direct Bilirubin Levels Observed in Prolonged Neonatal Jaundice: A Retrospective Cohort Study. BMJ Paediatric Open Vol. 2(1), Pp. e000202.
Lakshminarayanan, B., Davenport, M., 2016. Biliary Atresia: A Comprehensive Review. Journal of Autoimmunity Vol. 73, Pp. 1-9.
Liao, F.-M., Chang, K.-C., Wu, J.-F., Chen, H.-L., Ni, Y.-H., Chang, M.-H., 2022. Direct Bilirubin and Risk of Biliary Atresia. Pediatrics Vol. 149(6), e2021053073.
Lykavieris, P., Chardot, C., Sokhn, M., Gauthier, F., Valayer, J., Bernard, O., 2005. Outcome in Adulthood of Biliary Atresia: A Study of 63 Patients who Survived for Over 20 Years with Their Native Liver. Hepatology Vol. 41(2), Pp. 366-371.
Maisels, M.J., Clune, S., Coleman, K., Gendelman, B., Kendall, A., McManus, S., Smyth, M., 2014. The Natural History of Jaundice in Predominantly Breastfed Infants. Pediatrics Vol. 134(2), Pp. e340-345.
McKiernan, P.J., Baker, A.J., Lloyd, C., Mieli-Vergani, G., Kelly, D.A., 2009. British Paediatric Surveillance Unit Study of Biliary Atresia: Outcome at 13 Years. Journal of Pediatric Gastroenterology and Nutrition Vol. 48(1), Pp. 78-81.
Okajima, K., Nagaya, K., Azuma, H., Suzuki, T., 2016. Biliary Atresia and Stool: Its Consistency and Fat Content, Another Potentially Useful Clinical Information. European Journal of Gastroenterology & Hepatology Vol. 28(1), Pp. 118.
Patel, K.R., 2023. Biliary Atresia and Its Mimics. Diagnostic Histopathology Vol. 29(1), Pp. 52-66.
Russo, P., Magee, J.C., Anders, R.A., Bove, K.E., Chung, C., Cummings, O.W., Finegold, M.J., Finn, L.S., Kim, G.E., Lovell, M.A., Magid, M.S., Melin-Aldana, H., Ranganathan, S., Shehata, B.M., Wang, L.L., White, F.V., Chen, Z., Spino, C., Childhood Liver Disease Research Network (ChiLDReN), 2016. Key Histopathologic Features of Liver Biopsies That Distinguish Biliary Atresia From Other Causes of Infantile Cholestasis and Their Correlation With Outcome: A Multicenter Study. The American Journal of Surgical Pathology Vol. 40(12), Pp. 1601-1615.
Saito, T., Hishiki, T., Terui, K., Mitsunaga, T., Terui, E., Nakata, M., Yoshida, H., 2011. Toll-like Receptor mRNA Expression in Liver Tissue from Patients with Biliary Atresia. Journal of Pediatric Gastroenterology and Nutrition Vol. 53(6), Pp. 620-626.
Setyoboedi, B., Prihaningtyas, R., Utomo, M., Arief, S., 2022. Early Detection of Biliary Atresia in Primary Health Care: Still A Problem. F1000Research Vol. 11, Pp. 1245.
Siddiqui, A.H., Koirala, J., 2024. Methicillin-Resistant Staphylococcus aureus. In: StatPearls. StatPearls Publishing, Treasure Island (FL).
Vejchapipat, P., Poomsawat, S., Chongsrisawat, V., Honsawek, S., Poovorawan, Y., 2012. Elevated Serum IL-18 and Interferon-Gamma in Medium-Term Survivors of Biliary Atresia. European Journal of Pediatric Surgery Vol. 22(1), Pp. 29-33.
Vij, M., Rela, M., 2020. Biliary Atresia: Pathology, Etiology And Pathogenesis. Future Sci OA Vol. 6(5), Pp. FSO466.
Williams, D.M., 2018. Clinical Pharmacology of Corticosteroids. Respir Care Vol. 63(6), Pp. 655-670
Copyright (c) 2025 Journal of Vocational Health Studies
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
- The authors agree to transfer the transfer copyright of the article to the Journal of Vocational Health Studies (JVHS) effective if and when the paper is accepted for publication.
- Legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-NonCommercial-ShareAlike (CC BY-NC-SA), implies that publication can be used for non-commercial purposes in its original form.
- Every publications (printed/electronic) are open access for educational purposes, research, and library. Other that the aims mentioned above, editorial board is not responsible for copyright violation.
Journal of Vocational Health Studies is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
